BR0117062A - Methods to promote the development of edible animals, to substantially reduce or eliminate the incidence of disease and to produce a microbial adhesion inhibitor and microbial adhesion inhibitor. - Google Patents

Methods to promote the development of edible animals, to substantially reduce or eliminate the incidence of disease and to produce a microbial adhesion inhibitor and microbial adhesion inhibitor.

Info

Publication number
BR0117062A
BR0117062A BR0117062-7A BR0117062A BR0117062A BR 0117062 A BR0117062 A BR 0117062A BR 0117062 A BR0117062 A BR 0117062A BR 0117062 A BR0117062 A BR 0117062A
Authority
BR
Brazil
Prior art keywords
edible
animals
disease
promote
eliminate
Prior art date
Application number
BR0117062-7A
Other languages
Portuguese (pt)
Inventor
Peter Nash
Donald L Robinson
John W Rosevear
Original Assignee
Camas Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Camas Inc filed Critical Camas Inc
Publication of BR0117062A publication Critical patent/BR0117062A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
    • C07K2317/11—Immunoglobulins specific features characterized by their source of isolation or production isolated from eggs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Polymers & Plastics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Fodder In General (AREA)
  • Peptides Or Proteins (AREA)

Abstract

"MéTODOS PARA PROMOVER O DESENVOLVIMENTO DE ANIMAIS COMESTìVEIS, PARA SUBSTANCIALMENTE REDUZIR OU ELIMINAR A INCIDêNCIA DE DOENçAS E PARA PRODUZIR UM INIBIDOR DA ADERêNCIA MICROBIANA, E, INIBIDOR DA ADERêNCIA MICROBIANA" é apresentado um inibidor da aderência microbiana na fonna de anticorpos no ovo de aves domésticas, juntamente com o método de fabricá-lo e métodos de usá-los. O inibidor funciona por substancialmente impedir a ligação e aderência de imunógenos formadores de colónias no rúmem e tratos intestinais dos animais comestíveis hospedeiros. O inibidor é produzido mediante a inoculação das aves fêmeas com o imunógeno, colhendo os ovos que contêm os anticorpos com o imunógeno, secando os conteúdos dos ovos e adicionando-os na ração ou água para os animais hospedeiros. Dependendo do imunógeno particular com o qual a ave fêmea é inoculada, o anticorpo no ovo é usado para promover o desenvolvimento dos animais comestíveis por melhorar as taxas de conversão do alimento mediante a diminuição da perda de proteína dietética causada pela presença de certos organismos formadores de colónia nos animais, e substancialmente reduzir ou eliminar a incidência de doenças causadas pela presença de certos imunógenos formadores de colónia causadores de doença, tais como E. coli 0157:H7, na carne dos animais comestíveis, e em outros materiais comestiveis."METHODS TO PROMOTE EDIBLE ANIMAL DEVELOPMENT, SUBSTANTIALLY REDUCE OR ELIMINATE DISEASE INCIDENCE AND TO PRODUCE A MICROBIAN ADHERENCE INHIBITOR, AND, MICROBIAN ADHERENCE ADHIBITION IN BIRDS together with the method of manufacturing it and methods of using them. The inhibitor works by substantially preventing the binding and adherence of colony forming immunogens in the rumen and intestinal tract of the edible host animals. The inhibitor is produced by inoculating female birds with the immunogen by harvesting the eggs containing the antibodies with the immunogen, drying the egg contents and adding them to the feed or water for the host animals. Depending on the particular immunogen with which the female bird is inoculated, the antibody in the egg is used to promote the development of edible animals by improving feed conversion rates by decreasing the loss of dietary protein caused by the presence of certain food-forming organisms. colony in animals, and substantially reduce or eliminate the incidence of disease caused by the presence of certain disease-causing colony-forming immunogens, such as E. coli 0157: H7, in the meat of edible animals, and other edible materials.

BR0117062-7A 2001-12-28 2001-12-28 Methods to promote the development of edible animals, to substantially reduce or eliminate the incidence of disease and to produce a microbial adhesion inhibitor and microbial adhesion inhibitor. BR0117062A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2001/049588 WO2003061693A1 (en) 2001-12-28 2001-12-28 Immunogen adherence and method of making and using same

Publications (1)

Publication Number Publication Date
BR0117062A true BR0117062A (en) 2005-12-13

Family

ID=27608951

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0117062-7A BR0117062A (en) 2001-12-28 2001-12-28 Methods to promote the development of edible animals, to substantially reduce or eliminate the incidence of disease and to produce a microbial adhesion inhibitor and microbial adhesion inhibitor.

Country Status (8)

Country Link
EP (1) EP1476184A4 (en)
JP (1) JP2006504393A (en)
KR (1) KR20040096491A (en)
CN (1) CN1543355A (en)
AU (1) AU2002246753B8 (en)
BR (1) BR0117062A (en)
CA (1) CA2438698C (en)
WO (1) WO2003061693A1 (en)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4748018A (en) * 1984-02-07 1988-05-31 Stolle Research & Development Corp. Method of passive immunization of mammals using avian antibody
ES2052496T3 (en) * 1985-11-25 1994-07-16 Ghen Corp SUBSTANCE CONTAINING SPECIFIC ANTIBODY OBTAINED FROM EGGS AND METHOD FOR ITS PRODUCTION AND USE.
US5753228A (en) * 1992-08-25 1998-05-19 Arizona Board Of Regents On Behalf Of The University Of Arizona Method of treating parasitosis by the enteral administration of hyperimmune hen egg yolk antibodies
CA2218601A1 (en) * 1995-03-24 1996-10-03 Ophidian Pharmaceuticals, Inc. Treatment for verotoxin-producing escherichia coli
US5741489A (en) * 1996-05-24 1998-04-21 Anitox Corporation Passively administered antibody that enhances feed conversion efficiency
US5725873A (en) * 1996-07-22 1998-03-10 Wisconsin Alumni Research Foundation Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
AU729502B2 (en) * 1996-10-02 2001-02-01 Ovimmune, Inc. Oral administration of chicken yolk antibodies to treat disease
US6083500A (en) * 1997-10-06 2000-07-04 University Of Georgia Research Foundation, Inc. Biological control of food pathogens in livestock
CZ287989B6 (en) * 1998-03-20 2001-03-14 Medipharm Cz, S. R. O. Peroral preparation intended for prevention and treatment of infectious gastroenteritis in pigs
DE19910159A1 (en) * 1999-02-26 2000-09-14 Rosemarie Heis Specific IgY egg yolk antibodies, their extraction and their use
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
WO2001048018A1 (en) * 1999-12-27 2001-07-05 University Of Manitoba Genetic vaccines for the production of chicken egg-yolk antibodies against enterotoxigenic escherichia coli and other pathogens

Also Published As

Publication number Publication date
EP1476184A1 (en) 2004-11-17
CA2438698A1 (en) 2003-07-31
WO2003061693A1 (en) 2003-07-31
KR20040096491A (en) 2004-11-16
EP1476184A4 (en) 2006-01-04
JP2006504393A (en) 2006-02-09
CN1543355A (en) 2004-11-03
CA2438698C (en) 2013-12-17
AU2002246753B8 (en) 2009-09-24
AU2002246753B2 (en) 2009-05-28
AU2002246753A1 (en) 2003-09-02

Similar Documents

Publication Publication Date Title
Varnam et al. Meat and meat products: technology, chemistry and microbiology
Daş et al. Effect of extra dietary lysine in Ascaridia galli-infected grower layers
Grindstaff et al. Diet quality affects egg size and number but does not reduce maternal antibody transmission in Japanese quail Coturnix japonica
EP1324651A2 (en) Methods for raising pre-adult anadromous fish
RU2006131574A (en) APPLICATION OF LIVING BACTERIA TO STIMULATE ANIMAL GROWTH
HK1087949A1 (en) Immunogene adherence and method of making and using the same
Chikumba et al. Effects of water restriction on the growth performance, carcass characteristics and organ weights of naked neck and ovambo chickens of southern Africa
March et al. Trimethylamine production in the caeca and small intestine as a cause of fishy taints in eggs
van der Eijk et al. Fast-and slower-growing broilers respond similarly to a reduction in stocking density with regard to gait, hock burn, skin lesions, cleanliness, and performance
Bayes et al. The food and feeding behaviour of the great skua in the Faroes
Padilla Gaviiformes, podicipediformes, and procellariformes (loons, grebes, petrels, and albatrosses)
EP2377885A1 (en) Method for producing comprehensive anti-surface antibody wherein the antigen used is a microorganism fixed by a protein crosslinking and fixation reagent
BR0117062A (en) Methods to promote the development of edible animals, to substantially reduce or eliminate the incidence of disease and to produce a microbial adhesion inhibitor and microbial adhesion inhibitor.
Abbas et al. Future of ostrich farming in Pakistan
Sarlak et al. Effects of time of initiation of feeding after hatching and diet composition on performance, carcass characteristics, digestive tract development and immune responses of broilers
Rebezov et al. Features of protein metabolism in turkeys of different genotypes and age
Ingerslev et al. Previous bacterial infection affects textural quality parameters of heat‐treated fillets from rainbow trout (Oncorhynchus mykiss)
Tryland et al. Health and diseases of semi-domesticated reindeer in a climate change perspective
Aschfalk et al. Seroprevalence of Salmonella spp. in wild reindeer (Rangifer tarandus tarandus) in Iceland
Debnath Duck Production and Management
de Jong Welfare issues in poultry housing and management: broilers
Chatoo et al. Comparative Study of Production Performance among Local Quails
Cotter Dietary selenium in cultured hybrid striped bass
Hangui et al. Plastic responses to different types of cue: predator-induced and deep-water-induced polyphenisms in a salamander Hynobius retardatus
KR100592550B1 (en) The production method of blue colored egg and thereof blue colored egg

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O, 13 DA LPI

B12B Appeal: appeal against refusal
B15K Others concerning applications: alteration of classification

Ipc: C07K 16/12 (2006.01), A23K 20/147 (2016.01), A61K